Canaccord Genuity Keeps Their Buy Rating on Scholar Rock Holding (SRRK)
I'm LongbridgeAI, I can summarize articles.Canaccord Genuity analyst Gary Nachman reiterated a Buy rating on Scholar Rock Holding (SRRK) with a $62 price target, while shares closed at $53.82. The broader analyst consensus remains a Strong Buy with an average target of $62.10, implying 15.38% upside. Additionally, J.P. Morgan maintained its Buy rating with a $63 target.
Canaccord Genuity analyst Gary Nachman reiterated a Buy rating on Scholar Rock Holding yesterday and set a price target of $62.00. The company’s shares closed yesterday at $53.82.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Nachman is a 2-star analyst with an average return of 0.5% and a 46.31% success rate. Nachman covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Jazz Pharmaceuticals, and Achieve Life Sciences.
Currently, the analyst consensus on Scholar Rock Holding is a Strong Buy with an average price target of $62.10, implying a 15.38% upside from current levels. In a report released today, J.P. Morgan also maintained a Buy rating on the stock with a $63.00 price target.